Loxo Oncology CS (LOXO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Operating Expenses | 11,750 | 12,938 | 8,813 | 8,099 | 6,225 |
| Operating Income | -11,750 | -12,938 | -8,813 | -8,099 | -6,225 |
| Other Income | 153 | 71 | 42 | 43 | 43 |
| Pre-tax Income | -11,597 | -12,867 | -8,771 | -8,056 | -6,182 |
| Net Income Continuous | -11,597 | -12,867 | -8,771 | -8,056 | -6,182 |
| Net Income | $-11,597 | $-12,867 | $-8,771 | $-8,056 | $-6,182 |
| EPS Basic Total Ops | -0.59 | -0.72 | -0.53 | -0.49 | -0.38 |
| EPS Basic Continuous Ops | -0.59 | -0.73 | -0.53 | -0.49 | -0.38 |
| EPS Diluted Total Ops | -0.59 | -0.72 | -0.53 | -0.49 | -0.38 |
| EPS Diluted Continuous Ops | -0.59 | -0.73 | -0.53 | -0.49 | -0.38 |
| EBITDA(a) | $-11,629 | $-12,826 | $-8,674 | $-8,002 | $-6,165 |